Abstract
Initial burst release of drugs is a major shortcoming which needs to be addressed in treating osteomyelitis by using drug delivery systems (DDS). The aim of this study was to develop a novel DDS for reducing initial burst release based on the combination of chitosan (CS) microspheres and calcium polyphosphate/chitosan/aldehyde alginate (CPP/CS/ADA) composite scaffolds. CS microspheres and CPP/CS/ADA composite scaffolds were characterized by FTIR spectroscopy, a laser particle size analyzer and SEM in order to reveal their composition, size distribution and surface morphology. Tetracycline hydrochloride (TC), as a model drug in the study, was encapsulated in CS microspheres, which further combined with CPP/CS/ADA composite scaffolds to form new DDS. Then the in vitro drug release was studied in detail. The kinetics of the drug release was also systematically studied. The results indicate that this new microspheres/scaffold compound system has a promising potential to reduce initial drug burst release effectively and prolong drug release time even for 30 days.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
